169 engineering-computation "https:" "https:" "https:" "https:" "https:" "Simons Foundation" positions at Leibniz
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
The Leibniz Institute for Agricultural Engineering and Bioeconomy (ATB) is a pioneer and a driver of bioeconomy research. We create the scientific foundation to transform agricultural, food
-
. or comparable) in (bio-)physics, (bio-)chemistry, materials science, mechanical/(bio)chemical engineering or similar fields. Highly motivated and team-oriented Passion for multidisciplinary research and eagerness
-
(TIB ) – Leibniz Information Centre for Science and Technology – Program Area C, Research and Development, is looking to employ a Data Engineer/ Research Data Manager (m/f/d) to work in the Open Science
-
The Bernhard Nocht Institute for Tropical Medicine (https://www.bnitm.de/en/ ) is the largest Research Institute for Tropical Medicine in Germany and is the National Reference Centre for Tropical
-
facilities and state-of-the-art infrastructure to study the chemical diversity, biochemical interactions and biological functions of small natural product molecules in and from plants and fungi (https
-
Have: You are enrolled in a Master’s program in biochemistry, molecular biology, chemistry, biotechnology, biophysics, or a related field. You have a strong interest in experimental work and a curiosity
-
. or comparable) in (bio-)physics, (bio-)chemistry, materials science, mechanical/(bio)chemical engineering or similar fields. Highly motivated and team-oriented Passion for multidisciplinary research and eagerness
-
The LIT - Leibniz Institute for Immunotherapy (foundation under civil law) (https://lit.eu/ ) formerly RCI – is a biomedical research center focusing on translational immunology in the fields
-
Brandenburg. Support data analysis using pre-developed scripts in R Your qualifications: Currently enrolled in a Bachelor’s or Master’s program in Environmental Sciences, Engineering, Agriculture, Horticulture
-
CANCER (F/M/D) Starting on May 1st, 2026 (with flexibility). We have pioneered the development of synthetic tumor immune microenvironments, engineered from artificial cells that mimic immune functions